Home › Triple-Negative Breast Cancer › NCT07513311

A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer

Pilot Feasibility Trial of a Nurse-Led, Coping and Supportive Intervention (RESTORE) for Patients With Triple-Negative Breast Cancer

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Diagnosis of stage 1-3 triple-negative breast cancer
* Age ≥ to 18 years
* Between one and 12 months post curative therapy
* Reporting distress at least 4/10 on a one-item screener
* Ability to read and respond in English or Spanish

Exclusion Criteria:

* Patients with stage 4 cancer
* Patients with impaired cognition or serious mental illness that would preclude participation in study procedures

About the study

The purpose of this study is to explore the feasibility and acceptability of a nurse-led, coping, and supportive care intervention for patients with triple-negative breast cancer. The intervention aims to improve psychosocial outcomes in patients with triple-negative breast cancer (e.g., quality of life (QOL), anxiety, fear of cancer recurrence (FCR)).

What is being tested

• RESTORE (behavioral)
• Enhanced Usual Care (behavioral)

Sponsor: Massachusetts General Hospital · Participants: 75 · Started: Jul 7, 2026

Contact the study team

• Kathryn E Post, PhD, RN, ANP-BC · Phone: 617-726-6500

Official record on ClinicalTrials.gov — NCT07513311

Locations in the U.S.

Conditions

• Triple-Negative Breast Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.